Beaver Run Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Uncovering Mechanisms of Immune-Based Therapy in Cancer and Autoimmunity (B3)

Scientific Organizers: Daniel J. Cua, E. John Wherry and Carla V. Rothlin


February 18—22, 2019

Beaver Run Resort, Breckenridge, Colorado, USA


Held in honor of cancer immunotherapy research pioneers Dr. Alan Korman and Dr. Nils Lonberg, thanks to generous support from an anonymous donor.

Organized in collaboration with Cancer Research UK

Sponsored by AbbVie Inc., BioLegend, Inc., Compass Therapeutics, EMD Serono Research and Development Institute, Inc., Genentech, Inc., Incyte Corporation, MacroGenics, Inc., Merck & Co., Inc., OncoMed Pharmaceuticals, Inc., MorphoSys AG, Pfizer Inc., Roche, Surface Oncology and Takeda Pharmaceutical Company Limited


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 23, 2018 [details]
Discounted Abstract Deadline: Oct 23, 2018 [details]
Abstract Deadline: Nov 15, 2018 [details]
Discounted Registration Deadline: Dec 18, 2018 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-B3 "Uncovering Mechanisms of Immune-Based Therapy in Cancer and Autoimmunity" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 23, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 23, 2018 until January 7, 2019 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 23, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 18, 2018 845.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 18, 2018 1045.00 USD
Discounted STUDENT Registration
More details
Before and On December 18, 2018 620.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 18, 2018 820.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 23, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 15, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 23, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 15, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 23, 2018)

Discounted Registration Deadline: December 18, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 24 hr (international) time


The meeting will begin on Monday, February 18 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Friday, February 22 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Saturday, February 23 in order to fully experience the meeting.

MONDAY, FEBRUARY 18

4:00—8:00 PM
Arrival and Registration

Colorado Ballroom Foyer
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Colorado Ballroom Foyer

TUESDAY, FEBRUARY 19

7:00—8:00 AM
Breakfast

Summit Gallery
8:00—9:00 AM
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Arlene H. Sharpe, Harvard Medical School, USA
Checkpoint Blockade for Cancer Immunotherapy

9:00—11:15 AM
Checkpoint Blockade Predisposes Patients to Autoimmunity
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Jeffrey A. Bluestone, University of California, San Francisco, USA
Development of Syngeneic NOD Tumor Models to Study Tumor Immunity in Autoimmune-Prone Mice

Coffee Break

Jennifer Ann Wargo, University of Texas MD Anderson Cancer Center, USA
Immune Mechanisms Influencing Checkpoint Therapy

Dario A. A. Vignali, University of Pittsburgh School of Medicine, USA
Regulation of Autoimmunity and Cancer by PD-1 and LAG3

Short Talk(s) Chosen from Abstracts

11:15 AM—5:00 PM
On Own for Lunch

11:15 AM—1:00 PM
Poster Setup

Breckenridge Ballroom
1:00—10:00 PM
Poster Viewing

Breckenridge Ballroom
4:30—5:00 PM
Coffee Available

Colorado Ballroom Foyer
5:00—7:00 PM
Genetics of Autoimmunity and Cancer: What are the Common Denominators?
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Alex Marson, University of California, San Francisco, USA
Reprogramming Human Immune Cell Circuitry

Elissa K. Deenick, Garvan Institute of Medical Research, Australia
Talk Title to be Announced

Wenjun Ouyang, Amgen, Inc., USA
Lessons from Human Genetics for Autoimmunity and Cancer Therapy

Short Talk(s) Chosen from Abstracts

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
7:30—10:00 PM
Poster Session 1

Breckenridge Ballroom

WEDNESDAY, FEBRUARY 20

7:00—8:00 AM
Breakfast

Summit Gallery
8:00—11:00 AM
Cellular Reprogramming: Regulatory vs. Functional Fate
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Alexander Y. Rudensky, HHMI/Memorial Sloan Kettering Cancer Center, USA
Treg Stability in Disease

Mark S. Anderson, University of California, San Francisco, USA
Modulating Self-Tolerance in Autoimmunity and Cancer

Coffee Break

Maria Grazia Roncarolo, Stanford University School of Medicine, USA
T Regulatory Cell-Based Therapy in Cancer and Autoimmunity

Eric Meffre, Yale University School of Medicine, USA
Impaired B Cell Tolerance and Autoimmunity: CTLA-4 Blockade Dirty Secret

Short Talk(s) Chosen from Abstracts

11:00 AM—5:00 PM
On Own for Lunch

11:00 AM—1:00 PM
Poster Setup

Breckenridge Ballroom
1:00—10:00 PM
Poster Viewing

Breckenridge Ballroom
2:30—4:30 PM
Workshop 1: Immune Monitoring of Checkpoint Blockade Therapies

Colorado Ballroom
Short Talks Chosen from Abstracts

4:30—5:00 PM
Coffee Available

Colorado Ballroom Foyer
5:00—7:00 PM
Cellular Reprogramming: CD8 T Cell Exhaustion and CD4 T Cell Lineages
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
E. John Wherry, University of Pennsylvania, USA
T Cell Exhaustion and Fate Decisions – Implications for Immunotherapy

Andrea Schietinger, Memorial Sloan Kettering Cancer Center, USA
Epigenetics of Tumor Immunity

W. Nicholas Haining, Dana-Farber Cancer Institute, USA
Epigenetic Engineering of Tumor Immunity

Short Talk(s) Chosen from Abstracts

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
7:30—10:00 PM
Poster Session 2

Breckenridge Ballroom

THURSDAY, FEBRUARY 21

7:00—8:00 AM
Breakfast

Summit Gallery
8:00—11:00 AM
Macrophage Biology, Tissue Repair, Autoimmunity and Cancer
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Mikael J. Pittet, Massachusetts General Hospital, USA
Myeloid Cells in Cancer Therapies

Carla V. Rothlin, Yale University, USA
Coincidence Detectors in Tissue Repair

Coffee Break

Ming O. Li, Memorial Sloan Kettering Cancer Center, USA
Deconstructing the Antigen-Presenting Cell Compartment in Cancer

Fiona M. Powrie, University of Oxford, UK
Inflammation Driven Cancer: Host and Microbial Pathways

Short Talk(s) Chosen from Abstracts

11:00 AM—5:00 PM
On Own for Lunch

11:00 AM—1:00 PM
Poster Setup

Breckenridge Ballroom
1:00—10:00 PM
Poster Viewing

Breckenridge Ballroom
4:30—5:00 PM
Coffee Available

Colorado Ballroom Foyer
5:00—7:00 PM
Neutrophils and MDSCs in Host Defense and Cancer
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Matthew F. Krummel, University of California, San Francisco, USA
Myeloid Cells as Arbiters of Self

Catherine Hedrick, La Jolla Institute for Allergy and Immunology, USA
Neutrophil Heterogeneity in Cancer

Susan M. Kaech, The Salk Institute, USA
Nutrient Regulation of Anti-Tumor Immunity

Dmitry I. Gabrilovich, Wistar Institute, USA
Neutrophils and PMN-MDSC in Cancer: Two Sides of Functional Diversity

Short Talk(s) Chosen from Abstracts

7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
7:30—10:00 PM
Poster Session 3

Breckenridge Ballroom

FRIDAY, FEBRUARY 22

7:00—8:00 AM
Breakfast

Summit Gallery
8:00—11:00 AM
Finding the Cure for Cancer
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Drew M. Pardoll, Johns Hopkins University School of Medicine, USA
Checkpoint Inhibition

Alan J. Korman, Bristol-Myers Squibb, USA
Immune Checkpoint Blockade and Adverse Events in Mice, Cynos and Man

Coffee Break

Emmett V. Schmidt, Merck Research Labs, USA
Drivers in the Clinical Development of Cancer Combination Therapy – Pembrolizumab Combination Therapies, Emerging Results

Robert L. Coffman, Dynavax Technologies, USA
Talk Title to be Announced

Short Talk(s) Chosen from Abstracts

11:00 AM—5:00 PM
On Own for Lunch

4:30—5:00 PM
Coffee Available

Colorado Ballroom Foyer
5:00—6:45 PM
Integrated Themes across Preclinical and Clinical Treatment of Cancer and Autoimmunity
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
Mark J. Smyth, QIMR Berghofer Medical Research Institute, Australia
What we can Learn from Combination Immunotherapy

Hergen Spits, University of Amsterdam, Netherlands
Harnessing the Power of the Immune System for Therapy:Past Present and Future

Daniel J. Cua, Merck Research Laboratories, USA
Autoimmunity

Short Talk Chosen from Abstracts

6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/18/2019

Colorado Ballroom
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Breckenridge Ballroom
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Breckenridge Ballroom

SATURDAY, FEBRUARY 23

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

AbbVie Inc. BioLegend, Inc.
Organized in collaboration with Cancer Research UK Compass Therapeutics
EMD Serono Research and Development Institute, Inc. Genentech, Inc.
Incyte Corporation MacroGenics, Inc.
Merck & Co., Inc. MorphoSys AG
OncoMed Pharmaceuticals, Inc. Pfizer Inc.
Roche Surface Oncology
Takeda Pharmaceutical Company Limited
 

We gratefully acknowledge additional support from these exhibitors at this conference:

AYOXXA Biosystems Inc.
Please stop by to meet these exhibitors during the conference.


We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 CA232437-01

Funding for this conference was made possible (in part) by 1 R13 CA232437-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676